Reckitt Benckiser is being accused of misleading customers with specific pain treating products which were the same as standard Nurofen tablets however priced at nearly double the amount. A $6 million dollar charge is being pursued by the Australian Competition and Consumer Commission (ACCC) against Nurofen...